clinical trial

  • August 18, 2010  

    An effort to develop a treatment for Alzheimer’s disease was halted after data showed that a new drug was doing more harm than good, leading to more memory loss and putting people at a higher risk for skin cancer. Judy Woodruff discusses the findings with Dr. Paul Aisen of the University of California, San Diego. Continue reading

  • March 26, 2008   BY  

    The head of the federal government’s AIDS vaccine research program said Tuesday that the focus should shift from large-scale human vaccine trials back to basic research. Continue reading